Open access
65
Views
1
CrossRef citations to date
0
Altmetric
Review
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
Sujit V JanardhanCenter for Liver Diseases, Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago, IL, USA
& Nancy S ReauCenter for Liver Diseases, Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago, IL, USACorrespondence[email protected]
Pages 11-20
|
Published online: 16 Apr 2015
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.